Skip to main content
. 2014 Jun 10;2014(1):9. doi: 10.1186/1687-9856-2014-9

Table 1.

Protein spot displaying intensity differences (p < 0.05) between obese children (OB) and controls (C) before FDR analysis

Spot Spot intensity in OB
MS
MS
MS
MS -MS
MS-MS
MS-MS
Identification
Significance level
Score/Cut-off Matched fragments Sequence coverage (%) Score/Cut-off Matched (Significant) fragments Sequence coverage (%)
 
1809
Upregulated, p < 0.05
68/66
15
26
45/40
2 (1)
6
Alpha 1B acid glycoprotein
2201
Downregulated, p < 0.01
115/66
12
50
98/41
9 (6)
40
Apolipoprotein A1
2203
Downregulated, p < 0.05
44/66
3
--
102/41
3(3)
6
Clusterin (Apolipoprotein J)
2301
Downregulated, p < 0.05
56/66
7
--
95/41
5(4)
23
Clusterin (Apolipoprotein J)
2306
Upregulated, p < 0.05
75/66
7
30
71/41
6(2)
17
Haptoglobin
3201
Downregulated, p < 0.05
137/66
16
59
81/41
8(4)
33
Apolipoprotein A1
3202
Downregulated, p < 0.01
71/66
8
34
81/41
6(4)
25
Apolipoprotein A1
3307
Upregulated, p < 0.05
91/66
7
36
61/58
3(1)
6
Haptoglobin
4401
Downregulated, p < 0.05
68/66
6
83
95/59
2(2)
28
Transthyretin chain A
5603
Downregulated, p < 0.05
71/66
6
11
79/59
3(1)
6
Haptoglobin
5604
Downregulated, p < 0.01
82/66
11
49
84/58
2(1)
4
Haptoglobin
6203
Downregulated, p < 0.05
127/66
17
65
76/58
6(3)
29
Apolipoprotein A1
7102
Upregulated, p < 0.01
55/66
8
--
64/56
2(1)
13
Haptoglobin (alpha2)
7201
Downregulated, p < 0.01
106/66
16
66
76/59
3(2)
13
Apolipoprotein A1
7503
Downregulated, p < 0.05
53/66
5
--
64/58
2(2)
7
Vitamin D binding protein
8102
Upregulated, p < 0.01
68/66
5
20
70/57
3(1)
8
Haptoglobin (alpha2)
9101 Upregulated, p < 0.05 49/66 3 -- 105/55 1(1) 4 Haptoglobin (alpha2)

Protein spots displaying significant intensity differences between obese children (OB) and controls (C) prior to the false discovery rate (FDR) analysis. The spot in bold (8102) remained significantly different after FDR analysis. The second column shows the direction of the change observed in OBvs.C. Abbreviations:MS Mass spectrometry; MS-MS Tandem mass spectrometry.